SHR-8068 Combined With Adbelizumab and BP102 in the Treatment of Advanced Colorectal Cancer

NCT06373133 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

NOT_YET_RECRUITING

Status

36

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Cancer

Interventions

DRUG: SHR-8068
DRUG: Adebrelimab
DRUG: BP102

Sponsor

West China Hospital